Michael Hölzel

10.4k total citations
96 papers, 4.3k citations indexed

About

Michael Hölzel is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael Hölzel has authored 96 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Oncology, 37 papers in Molecular Biology and 24 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael Hölzel's work include Cancer Immunotherapy and Biomarkers (18 papers), Immunotherapy and Immune Responses (10 papers) and Bladder and Urothelial Cancer Treatments (10 papers). Michael Hölzel is often cited by papers focused on Cancer Immunotherapy and Biomarkers (18 papers), Immunotherapy and Immune Responses (10 papers) and Bladder and Urothelial Cancer Treatments (10 papers). Michael Hölzel collaborates with scholars based in Germany, United States and United Kingdom. Michael Hölzel's co-authors include Thomas Tüting, Dirk Eick, Tobias Bald, Rohrmoser Michaela, Malamoussi Anastassia, Elisabeth Kremmer, Jennifer Landsberg, Anton Bovier, Harasim Thomas and Marcel Renn and has published in prestigious journals such as Nature, Cell and Nucleic Acids Research.

In The Last Decade

Michael Hölzel

91 papers receiving 4.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Hölzel Germany	33	2.2k	1.7k	1.3k	588	443	96	4.3k
Laura Soucek Spain	32	3.7k 1.6×	1.7k 1.0×	855 0.6×	858 1.5×	305 0.7×	54	5.0k
Donald L. Durden United States	38	3.3k 1.5×	1.1k 0.7×	997 0.7×	1.0k 1.7×	375 0.8×	108	5.3k
János L. Tanyi United States	36	1.9k 0.9×	1.7k 1.0×	887 0.7×	720 1.2×	378 0.9×	113	3.9k
Paulette Mhawech‐Fauceglia United States	35	1.9k 0.9×	2.0k 1.2×	1.6k 1.2×	689 1.2×	676 1.5×	126	5.0k
Stefania Scala Italy	42	2.0k 0.9×	2.8k 1.6×	1.5k 1.1×	930 1.6×	560 1.3×	130	5.1k
Ann Zeuner Italy	35	2.4k 1.1×	1.4k 0.8×	879 0.7×	867 1.5×	275 0.6×	72	4.3k
Maria Rita Nicotra Italy	42	2.3k 1.0×	1.3k 0.7×	802 0.6×	577 1.0×	412 0.9×	79	4.3k
Christina M. Annunziata United States	37	2.5k 1.1×	2.6k 1.5×	1.2k 0.9×	1.0k 1.7×	531 1.2×	155	5.4k
Sylvain Baulande France	26	1.4k 0.6×	1.1k 0.7×	969 0.7×	778 1.3×	624 1.4×	72	3.4k
Cornelius Miething Germany	28	3.0k 1.3×	1.5k 0.9×	1.2k 0.9×	740 1.3×	299 0.7×	68	5.1k

Countries citing papers authored by Michael Hölzel

Since Specialization

Citations

This map shows the geographic impact of Michael Hölzel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Hölzel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Hölzel more than expected).

Fields of papers citing papers by Michael Hölzel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Hölzel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Hölzel. The network helps show where Michael Hölzel may publish in the future.

Co-authorship network of co-authors of Michael Hölzel

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Hölzel. A scholar is included among the top collaborators of Michael Hölzel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Hölzel. Michael Hölzel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wefers, Benedikt, Maike Effern, Dániel Péter Varga, et al.. (2025). RNase T2 restricts TLR13-mediated autoinflammation in vivo. The Journal of Experimental Medicine. 222(3). 2 indexed citations

Dold, Leona, Bettina Langhans, Dominik J. Kaczmarek, et al.. (2025). The IL-6/JAK/STAT3 Axis in Cholangiocarcinoma and Primary Sclerosing Cholangitis: Unlocking Therapeutic Strategies Through Patient-Derived Organoids. Biomedicines. 13(5). 1083–1083. 2 indexed citations

Klümper, Niklas, Vittorio Branchi, Alexander Semaan, et al.. (2025). The Antibody–Drug Conjugate Sacituzumab Govitecan (IMMU-132) Represents a Potential Novel Therapeutic Strategy in Cholangiocarcinoma. Molecular Cancer Therapeutics. 24(11). 1775–1788. 1 indexed citations

Klümper, Niklas, Vittorio Branchi, Alexander Semaan, et al.. (2025). Figure S1 from The Antibody–Drug Conjugate Sacituzumab Govitecan (IMMU-132) Represents a Potential Novel Therapeutic Strategy in Cholangiocarcinoma. Figshare.

Eckstein, Markus, Manuel Ritter, Peter Brossart, et al.. (2024). The modified Glasgow Prognostic Score (mGPS) can guide decisions for immunotherapy treatment beyond progression. European Journal of Cancer. 215. 115163–115163. 3 indexed citations

Strissel, Pamela L., Reiner Strick, Carol Geppert, et al.. (2024). Associations of TACSTD2/TROP2 and NECTIN‐4/NECTIN‐4 with molecular subtypes, PD‐L1 expression, and FGFR3 mutational status in two advanced urothelial bladder cancer cohorts. Histopathology. 84(5). 863–876. 17 indexed citations

Amaral, Teresa, Oltin T. Pop, Tobias Sinnberg, et al.. (2023). EGFR expression and relapse in patients with melanoma receiving adjuvant PD-1-based immunotherapy.. Journal of Clinical Oncology. 41(16_suppl). e21566–e21566. 1 indexed citations

Strissel, Pamela L., Reiner Strick, Carol‐Immanuel Geppert, et al.. (2023). Associations of TACSTD2/TROP2 and NECTIN-4/NECTIN-4 with molecular subtypes, PD-L1 expression and FGFR3 mutational status in two advanced urothelial bladder cancer cohorts.. Journal of Clinical Oncology. 41(6_suppl). 554–554. 1 indexed citations

Leonardelli, Sonia, Jennifer Landsberg, Raffaella Belvedere, et al.. (2023). The CD73 is induced by TGF-β1 triggered by nutrient deprivation and highly expressed in dedifferentiated human melanoma. Biomedicine & Pharmacotherapy. 165. 115225–115225. 10 indexed citations

10.

Ellinger, Jörg, et al.. (2023). Pretreatment albumin is a prognostic and predictive biomarker for response to atezolizumab across solid tumors. Clinical & Translational Immunology. 12(11). e1472–e1472. 6 indexed citations

11.

Klümper, Niklas, Fiamma Berner, Annkristin Heine, et al.. (2022). C reactive protein flare predicts response to checkpoint inhibitor treatment in non-small cell lung cancer. Journal for ImmunoTherapy of Cancer. 10(3). e004024–e004024. 53 indexed citations

12.

Link, Barbara, Adriana Torres Crigna, Michael Hölzel, Frank A. Giordano, & Olga Golubnitschaja. (2021). Abscopal Effects in Metastatic Cancer: Is a Predictive Approach Possible to Improve Individual Outcomes?. Journal of Clinical Medicine. 10(21). 5124–5124. 16 indexed citations

13.

Ruotsalainen, Janne, Dorys Lopez-Ramos, Meri Rogava, et al.. (2021). The myeloid cell type I IFN system promotes antitumor immunity over pro‐tumoral inflammation in cancer T‐cell therapy. Clinical & Translational Immunology. 10(4). e1276–e1276. 5 indexed citations

14.

Ataide, Marco A., Konrad Knöpper, Annika E. Peters, et al.. (2020). BATF3 programs CD8+ T cell memory. Nature Immunology. 21(11). 1397–1407. 88 indexed citations

15.

Kobler, Erich, et al.. (2019). Joint reconstruction and classification of tumor cells and cell interactions in melanoma tissue sections with synthesized training data. International Journal of Computer Assisted Radiology and Surgery. 14(4). 587–599. 6 indexed citations

16.

Young, Arabella, Shin Foong Ngiow, Jason Madore, et al.. (2017). Targeting Adenosine in BRAF-Mutant Melanoma Reduces Tumor Growth and Metastasis. Cancer Research. 77(17). 4684–4696. 76 indexed citations

17.

Hölzel, Michael, Jennifer Landsberg, Nicole Glodde, et al.. (2015). A Preclinical Model of Malignant Peripheral Nerve Sheath Tumor-like Melanoma Is Characterized by Infiltrating Mast Cells. Cancer Research. 76(2). 251–263. 30 indexed citations

18.

Riesenberg, Stefanie, Robert Siddaway, Tobias Bald, et al.. (2015). MITF and c-Jun antagonism interconnects melanoma dedifferentiation with pro-inflammatory cytokine responsiveness and myeloid cell recruitment. Nature Communications. 6(1). 8755–8755. 153 indexed citations

19.

Bald, Tobias, Jennifer Landsberg, Dorys Lopez-Ramos, et al.. (2014). Immune Cell–Poor Melanomas Benefit from PD-1 Blockade after Targeted Type I IFN Activation. Cancer Discovery. 4(6). 674–687. 196 indexed citations

20.

Heuckmann, Johannes M., Michael Hölzel, Martin L. Sos, et al.. (2011). ALK Mutations Conferring Differential Resistance to Structurally Diverse ALK Inhibitors. Clinical Cancer Research. 17(23). 7394–7401. 147 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact